Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 63Recruiting 24Unknown 22Terminated 6Not yet recruiting 5Active not recruiting 5Withdrawn 3Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Standard of Care 2Robotic Surgical Procedures 1Rifampin 1Practice Guidelines as Topic 1Platinum Compounds 1Patient Navigation 1Palliative Care 1Oxaliplatin 1Nivolumab 1Metronidazole 1Methods 1Leucovorin 1Interviews as Topic 1Hematologic Tests 1Folfox protocol 1Fluorouracil 1Educational Status 1Early Intervention, Educational 1Drug Therapy 1Colonoscopy 1Colectomy 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Colorectal Neoplasms × Folfox protocol × Clear all
NCT06936527 2025-09-03

XS-03-II201

NovaOnco Therapeutics Co., Ltd.

Phase 1/2 Enrolling by invitation
102 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡